24th - 26th March 2021

8th Edition MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference ( Time Zone - CENTRAL EUROPEAN TIME (CET)

The 8th Edition Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 25 - 26 March 2021 would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. 

Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
 

WHAT TO EXPECT
Key Highlights
  • Biomarker Drug Discovery and Assay Development
  • Proteomics and Genomics based Biomarkers
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
  • Commercialization of CDx
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
Who Should Attend?

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
CONFERENCE AGENDA
CLINICAL BIOMARKER IDENTIFICATION, QUALIFICATION AND PRECISION MEDICINE
TRANSLATIONAL AND CLINICAL BIOMARKER DRUG DISCOVERY AND ASSAY DEVELOPMENT
CONFERENCE SPEAKERS
Speakers
 Greg Kirchenbaum

Greg Kirchenbaum

Senior Scientist
Cellular Technology Limited, USA

Greg Kirchenbaum

Senior Scientist
Cellular Technology Limited, USA
George Pell

George Pell

CEO and Founder
Thirty-Six

George Pell

CEO and Founder
Thirty-Six
Ginette Serrero

Ginette Serrero

Chief Executive Officer
Precision Antibody, USA

Ginette Serrero

Chief Executive Officer
Precision Antibody, USA
Zev Gechtman

Zev Gechtman

Ph.D. Technical Product Manager
Abcam

Zev Gechtman

Ph.D. Technical Product Manager
Abcam
Keith Wharton

Keith Wharton

VP, Medical Director
Ultivue, USA

Keith Wharton

VP, Medical Director
Ultivue, USA
Mark Verardo

Mark Verardo

Senior Scientific Program Manager
Agilent Technologies, USA

Mark Verardo

Senior Scientific Program Manager
Agilent Technologies, USA
Daniel Enderle

Daniel Enderle

Scientific Director, Companion Diagnostics
Exosome Diagnostics, Germany

Daniel Enderle

Scientific Director, Companion Diagnostics
Exosome Diagnostics, Germany
Dr. Reinhard Ortmann

Dr. Reinhard Ortmann

Director Oncology & Precision Diagnostics
QIAGEN, Germany

Dr. Reinhard Ortmann

Director Oncology & Precision Diagnostics
QIAGEN, Germany
SPONSORS
Platinium
example-image

Larvol

example-image

NeoGenomics

example-image

Agilent

example-image

QIAGEN

Gold
example-image

Owlstone Medical

example-image

Proteome Sciences

Silver
example-image

Abcam

Speaking Partner
example-image

Boston Healthcare

example-image

HTG Molecular Diagnostics, Inc.

example-image

Precision Antibody

example-image

Cellular Technology Limited

Meeting Partner
example-image

Burning Rock

PARTNERS
Media Partners
example-image

PharmaVOICE

example-image

PharmaTutor

example-image

Pharma Journalist

PAST EVENT GALLERY